243 related articles for article (PubMed ID: 31694494)
1. Continuous angiogenesis inhibition in the treatment for von Hippel-Lindau-related hemangioblastomas of retina and spinal cord.
Salim DK
J Oncol Pharm Pract; 2019 Dec; 25(8):2049-2051. PubMed ID: 31694494
[TBL] [Abstract][Full Text] [Related]
2. Monotherapy with thalidomide for treatment of spinal cord hemangioblastomas in a patient with von Hippel-Lindau disease.
Sardi I; Sanzo M; Giordano F; Buccoliero AM; Mussa F; Aricò M; Genitori L
Pediatr Blood Cancer; 2009 Sep; 53(3):464-7. PubMed ID: 19415739
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiology, treatment and follow-up of central nervous system hemangioblastomas in von Hippel-Lindau disease].
Sankaredja J; Brac B; Thines L; Baroncini M; Zairi F; Cardot-Bauters C; Lejeune JP
Rev Neurol (Paris); 2014 Apr; 170(4):288-96. PubMed ID: 24680832
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms, indications and results of salvage systemic therapy for sporadic and von Hippel-Lindau related hemangioblastomas of the central nervous system.
Capitanio JF; Mazza E; Motta M; Mortini P; Reni M
Crit Rev Oncol Hematol; 2013 Apr; 86(1):69-84. PubMed ID: 23148943
[TBL] [Abstract][Full Text] [Related]
5. Variable response of CNS hemangioblastomas to Pazopanib in a single patient with von Hippel-Lindau disease: Case report.
Taylor DG; Ilyas A; Mehta GU; Chen CJ; Schiff D; Oldfield EH; Asthagiri AR
J Clin Neurosci; 2018 Apr; 50():154-156. PubMed ID: 29396065
[TBL] [Abstract][Full Text] [Related]
6. Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review.
Migliorini D; Haller S; Merkler D; Pugliesi-Rinaldi A; Koka A; Schaller K; Leemann B; Dietrich PY
CNS Oncol; 2015; 4(6):387-92. PubMed ID: 26497655
[TBL] [Abstract][Full Text] [Related]
7. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.
Wanebo JE; Lonser RR; Glenn GM; Oldfield EH
J Neurosurg; 2003 Jan; 98(1):82-94. PubMed ID: 12546356
[TBL] [Abstract][Full Text] [Related]
8. von Hippel-Lindau disease: treatment of retinal haemangioblastomas by targeted therapy with systemic bevacizumab.
Wackernagel W; Lackner EM; Pilz S; Mayer C; Stepan V
Acta Ophthalmol; 2010 Nov; 88(7):e271-2. PubMed ID: 20977691
[No Abstract] [Full Text] [Related]
9. Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences.
Yousef A; Rutkowski MJ; Yalcin CE; Eren OC; Caliskan I; Tihan T
J Neurooncol; 2019 Jul; 143(3):547-552. PubMed ID: 31089924
[TBL] [Abstract][Full Text] [Related]
10. Neurological Management of Von Hippel-Lindau Disease.
Hodgson TS; Nielsen SM; Lesniak MS; Lukas RV
Neurologist; 2016 Sep; 21(5):73-8. PubMed ID: 27564075
[TBL] [Abstract][Full Text] [Related]
11. [Intravitreal anti-VEGF therapy for capillary hemangioblastomas in von Hippel-Lindau disease].
Michels S; Messmer E; Sutter F; Kurz-Levin MM
Klin Monbl Augenheilkd; 2008 Apr; 225(4):292-4. PubMed ID: 18401796
[TBL] [Abstract][Full Text] [Related]
12. Von Hippel-Lindau with early onset of hemangioblastoma and multiple drop-metastases like spinal lesions: A case report.
Nguyen TH; Pham T; Strickland T; Brewer D; Belirgen M; Al-Rahawan MM
Medicine (Baltimore); 2018 Sep; 97(39):e12477. PubMed ID: 30278534
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic therapy for von Hippel-Lindau disease.
Madhusudan S; Deplanque G; Braybrooke JP; Cattell E; Taylor M; Price P; Tsaloumas MD; Moore N; Huson SM; Adams C; Frith P; Scigalla P; Harris AL
JAMA; 2004 Feb; 291(8):943-4. PubMed ID: 14982909
[No Abstract] [Full Text] [Related]
14. Comparison of anterior and posterior surgical approaches in the treatment of ventral spinal hemangioblastomas in patients with von Hippel-Lindau disease.
Pluta RM; Iuliano B; DeVroom HL; Nguyen T; Oldfield EH
J Neurosurg; 2003 Jan; 98(1):117-24. PubMed ID: 12546359
[TBL] [Abstract][Full Text] [Related]
15. Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas.
Girmens JF; Erginay A; Massin P; Scigalla P; Gaudric A; Richard S
Am J Ophthalmol; 2003 Jul; 136(1):194-6. PubMed ID: 12834696
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of sporadic and von Hippel-Lindau syndrome-associated intramedullary hemangioblastomas.
Prokopienko M; Kunert P; Podgórska A; Marchel A
Neurol Neurochir Pol; 2016; 50(5):349-55. PubMed ID: 27591060
[TBL] [Abstract][Full Text] [Related]
17. Functional outcome after resection of spinal cord hemangioblastomas associated with von Hippel-Lindau disease.
Mehta GU; Asthagiri AR; Bakhtian KD; Auh S; Oldfield EH; Lonser RR
J Neurosurg Spine; 2010 Mar; 12(3):233-42. PubMed ID: 20192620
[TBL] [Abstract][Full Text] [Related]
18. Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease.
Lonser RR; Weil RJ; Wanebo JE; DeVroom HL; Oldfield EH
J Neurosurg; 2003 Jan; 98(1):106-16. PubMed ID: 12546358
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
[TBL] [Abstract][Full Text] [Related]
20. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease.
Conway JE; Chou D; Clatterbuck RE; Brem H; Long DM; Rigamonti D
Neurosurgery; 2001 Jan; 48(1):55-62; discussion 62-3. PubMed ID: 11152361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
